Nucleic Acid Aptamer: A Novel Potential Diagnostic and Therapeutic Tool for Leukemia

Leukemia immunotherapy has been dominant via using synthetic antibodies to target cluster of differentiation (CD) molecules, nevertheless inevitable cytotoxicity and immunogenicity would limit its development. Recently, increasing reports have focused on nucleic acid aptamers, a class of high-affini...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yuan, Li, Yuejin, Tang, Faqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900352/
https://www.ncbi.nlm.nih.gov/pubmed/31824168
http://dx.doi.org/10.2147/OTT.S223946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900352/
https://www.ncbi.nlm.nih.gov/pubmed/31824168
http://dx.doi.org/10.2147/OTT.S223946

Ejemplares similares